Skip to main content
Premium Trial:

Request an Annual Quote

Cambridge University to Use Affy, ParAllele Tech in Diabetes Genotyping Study

NEW YORK, July 20 (GenomeWeb News) - A team of researchers at Cambridge University will use technology from Affymetrix and ParAllele in a study that will eventually genotype 20,000 type 1 diabetes patients, the companies said today.

 

The Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory at Cambridge will initially use Affy's GeneChip Tag Arrays and ParAllele's MegAllele genotyping reagents to compare genotypes between 1,000 control samples and 1,000 diabetic samples. The researchers will use ParAllele's standard panel of 10,000 non-synonymous SNPs for this phase of the study.

 

Eventually, the project will analyze more than 20,000 DNA samples that have already been collected from diabetes patients and their relatives, the companies said.

 

The project is the first that Affymetrix and ParAllele have jointly signed since they entered into a distribution agreement in May.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.